Source comparison
CJC-1295 vs MK-677 Which Better Comparison: Side Effect Profiles
CJC-1295 is generally well-tolerated in research models, with the most common adverse event being transient injection-site reactions lasting 24–48 hours. Because it amplifies endogenous GH pulses rather than overriding them, it rarely produces supraphysiologic
This comparison does not assign a generated winner or score.
- CJC-1295 is generally well-tolerated in research models, with the most common adverse event being transient injection-site reactions lasting 24–48 hours. Because it amplifies endogenous GH pulses rather than overriding them, it rarely produces supraphysiological GH spikes. However, high-dose protocols (>2mg weekly) can elevate GH and IGF-1 beyond normal ranges, potentially increasing the risk of insulin resistance, joint pain, and fluid retention.
- MK-677's side effect profile is dominated by ghrelin-mediated effects. Increased appetite is near-universal at therapeutic doses and can persist for the duration of dosing. Water retention is common, particularly in the first 2–4 weeks, due to aldosterone stimulation secondary to elevated GH. Some research models report transient increases in fasting blood glucose and HbA1c (0.3–0.5% above baseline), likely reflecting GH's counter-regulatory effects on insulin sensitivity.
- Neither compound is associated with significant hepatotoxicity, cardiovascular risk, or endocrine shutdown at standard research doses. The key distinction is that MK-677's side effects are metabolic and appetite-driven, while CJC-1295's are primarily injection-related and dose-dependent.